- Home
- MTSI vs RVMD Comparison
MTSI vs RVMD Comparison
Compare MTSI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTSI
- RVMD
- Stock Information
- Founded
- MTSI 1950
- RVMD 2014
- Country
- MTSI United States
- RVMD United States
- Employees
- MTSI N/A
- RVMD N/A
- Industry
- MTSI Semiconductors
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTSI Technology
- RVMD Health Care
- Exchange
- MTSI Nasdaq
- RVMD Nasdaq
- Market Cap
- MTSI 9.2B
- RVMD 7.4B
- IPO Year
- MTSI 2012
- RVMD 2020
- Fundamental
- Price
- MTSI $122.17
- RVMD $40.44
- Analyst Decision
- MTSI Strong Buy
- RVMD Strong Buy
- Analyst Count
- MTSI 9
- RVMD 12
- Target Price
- MTSI $130.00
- RVMD $68.67
- AVG Volume (30 Days)
- MTSI 848.2K
- RVMD 2.0M
- Earning Date
- MTSI 05-08-2025
- RVMD 05-07-2025
- Dividend Yield
- MTSI N/A
- RVMD N/A
- EPS Growth
- MTSI N/A
- RVMD N/A
- EPS
- MTSI N/A
- RVMD N/A
- Revenue
- MTSI $845,205,000.00
- RVMD N/A
- Revenue This Year
- MTSI $33.43
- RVMD N/A
- Revenue Next Year
- MTSI $11.97
- RVMD $241.39
- P/E Ratio
- MTSI N/A
- RVMD N/A
- Revenue Growth
- MTSI 32.63
- RVMD N/A
- 52 Week Low
- MTSI $84.00
- RVMD $29.17
- 52 Week High
- MTSI $152.50
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- MTSI 60.13
- RVMD 54.25
- Support Level
- MTSI $120.09
- RVMD $36.53
- Resistance Level
- MTSI $126.18
- RVMD $40.00
- Average True Range (ATR)
- MTSI 2.71
- RVMD 1.74
- MACD
- MTSI -0.56
- RVMD -0.11
- Stochastic Oscillator
- MTSI 45.80
- RVMD 64.44
About MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.